Match Document Document Title
7611701 Preparation of phytase-containing granulates for use in animal feed  
A process for the preparation of an enzyme-containing granulate is disclosed where an aqueous enzyme-containing liquid is mixed with an edible carbohydrate-based solid carrier, such as starch,...
7592167 Functional peptide fiber, production thereof and method for recovering peptide chains  
This invention provides a functional peptide fiber which comprises a plurality of peptide structure units each containing at least one peptide chain, wherein peptide chains contained in each...
7566556 Enhancing enzyme thermostability by mixing with sorghum liquor waste  
A composition containing a thermolabile protein admixed with a liquor waste. Also disclosed is a method of preparing such a composition which contains a protein with enhanced thermostability.
7524663 Covalently reactive transition state analogs and methods of use thereof  
Improved methods for the production, selection and inhibition of catalytic antibodies are disclosed.
7507585 Methods and systems for indentifying and monitoring S-nitrosothiols in biological samples  
The present invention describes methods and kits for determining the level of S-nitrosothiols in biological fluid samples. The method includes separating tissue or cellular matter from the...
7507540 Catalytic anti-factor VIII allo-antibodies  
A method is disclosed of determining the presence of catalytic anti-Factor VIII allo-antibodies capable of degrading Factor VIII in a mammal, and of characterising the cleavage sites in said Factor...
7482162 Determination of vitamin D metabolite and displacement from plasma or serum binding proteins  
We disclose methods for measuring vitamin D metabolite in plasma or serum samples. The methods comprise a step of adding to the plasma or serum samples a non-competitive displacement agent...
7482145 Deglycosylated enzymes for conjugates  
By deglycosylating an enzyme derived from a eukaryotic organism prior to forming a conjugate, i.e. prior to attaching the enzyme to a molecule capable of binding to a target molecule, the...
7456000 Deactivation of linking moieties in antibody-enzyme conjugates  
In some embodiments, the present invention pertains to a method for conjugating a first compound to a second compound wherein the conjugation involves an electrophilic moiety. The method comprises...
7419811 Use of specifically engineered enzymes to enhance the efficacy of prodrugs  
The invention provides methods for enhancing efficiency of prodrugs by specifically engineered enzymes with enhanced activity towards nucleoside analogs used in cancer chemotherapy, and delivering...
7419600 Method for purifying a branched water-soluble polymer  
Multi-armed, monofunctional, and hydrolytically stable polymers are described having the structure wherein Z is a moiety that can be activated for attachment to biologically active molecules...
7416869 Enzyme delivery systems, application in water based products  
Aqueous enzyme delivery systems as well as aqueous cosmetics and personal care products were provided which comprise at least one stabile enzyme and a polyglycerol containing at least 15 carbons....
7413884 Immunological control of β-amyloid levels in vivo  
Disclosed are antibodies which catalyze hydrolysis of β-amyloid. Antibodies generated are characterized by the amide linkage which they hydrolyze. Methods of generating the antibodies by using...
7413739 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds  
The invention features polymeric biomaterials formed by nucleophilic addition reactions to conjugated unsaturated groups. These biomaterials may be used for medical treatments.
7410755 ADP detection using an enzyme-coupled reaction  
Methods and compositions are provided for determining ADP in the presence of ATP. These comprise including among the assay reagents at least one of the correcting components creatine phosphokinase...
7393698 Magnetic fine particles and process for producing the same  
The present invention relates to magnetic fine particles having immobilized thereto a polymer having an upper critical solution temperature, and a process for producing the same, a method of...
7354750 Methods for separating molecules  
The present invention provides compositions and methods for the separation of metals or molecules such as polypeptides, nucleic acids, or endotoxins using a metal-modified solid support. The metals...
7351586 Method of making stable calibrators or controls for measuring human natriuretic peptides  
The present invention relates methods for making stable calibrators and controls that can be used in ligand-binding assays.
7345149 Cysteine substitution variants of beta interferon  
The growth hormone supergene family comprises greater than 20 structurally related cytokines and growth factors. A general method is provided for creating site-specific, biologically active...
7341720 Targeting of glycoprotein therapeutics  
Methods of making ligand-decorated polymer conjugates of therapeutic glycoproteins are described. Improved targeting of glycoproteins to specific tissues is achieved by masking the natural...
7338770 Human procalcitonin and the preparation and use thereof  
The invention relates to human procalcitonin and the preparation and use thereof. In particular, a process for preparing human procalcitonin is described wherein a gene coding for a polypeptide...
7335741 Means for use in diagnostics and/or therapy  
The present invention relates to a specific reagent for the detection of the CD30 molecule, whereby this reagent is suitable in particular for the diagnosis of lymphomas.
7335717 Methods, compositions, and biomimetic catalysts for the synthesis of silica, polysilsequioxanes, polysiloxanes, non-silicon metalloid-oxygen networks, polymetallo-oxanes, and their organic or hydrido conjugates and derivatives  
The in vitro polymerization of silica, silicone, non-silicon metalloid-oxane and metallo-oxane polymer networks, by combining a catalyst and a substrate to polymerize the substrate to form silica,...
7329528 Enzyme multimer and process of producing same  
An enzyme multimer is provided which comprises a plurality of monomer units including a first monomer unit having enzymatic activity and a second monomer unit having enzymatic activity, wherein...
7329516 Methods for increasing protein polyethylene glycol (PEG) conjugation  
The present invention relates to highly conjugated proteins and methods for making such proteins. In particular, the present invention relates to methods for linking additional sites to a protein...
7323167 Method of treatment with modified arginine deiminase  
The present invention is directed to arginine deiminase modified with polyethylene glycol, to methods of treating cancer, and to methods of treating and/or inhibiting metastasis.
7312056 Enhancement of enzyme activity through purification and immobilization  
An improved method of making an immobilized enzyme comprising (a) treating an immobilization support with an aqueous solution comprising a cross-linking agent and polymeric aldehyde species and...
7304016 Compositions for separating molecules  
The present invention provides compositions for the separation of metals or biomolecules such as polypeptides, nucleic acids, or endotoxins using modified solid supports.
7300779 Preparation of a granule containing protein, corn starch and sugar layered on an inert particle  
Granules that include a protein core are described. The protein core includes a protein matrix which includes a protein mixed together with a starch. The protein matrix can be layered over a seed...
7282567 Monoclonal antibody hPAM4  
This invention relates to monovalent and multivalent, monospecific antibodies and to multivalent, multispecific antibodies. One embodiment of these antibodies has one or more identical binding...
7273736 Method for preparing an enzyme containing granule  
The invention relates processes for producing enzyme containing granules having an enzyme containing core and a shell coating the core wherein the preparation of the core and application of the...
7247462 Coated enzyme-containing catalyst  
An enzymatic catalyst in the granular form which is non-dispersible in water comprising an inner core provided with a coating which coating comprises an enzymatic material characterised in that the...
7238786 Monoclonal antibody cPAM4  
This invention relates to monovalent and multivalent, monospecific antibodies and to monovalent and multivalent, multispecific antibodies. One embodiment of these antibodies has one or more...
7232888 Antibodies against tumor surface antigens  
The present invention relates to improved antibodies against tumor surface antigens and their use in the treatment of tumors. Of particular interest are highly stable, humanized, high affinity...
7229810 Polymer conjugates of proteinases  
Methods are provided for the stabilization of proteinases by the covalent attachment of or admixture with water-soluble polymers. The resultant stabilized proteinases have increased stability under...
7220842 Immunoassays for buprenorphine and norbuprenorphine  
Methods, compositions and kits are disclosed directed at haptens, immunogens and immunoassays for buprenorphine (BUP) and nor buprenorphine (norBUP). The method comprises providing in combination...
7217796 Neutralizing human anti-IGFR antibody  
The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing...
7217795 Tumor suppressor designated TS10q23.3  
A specific region of chromosome 10 (10q23.3) has been implicated by series of studies to contain a tumor suppressor gene involved in gliomas, as well as a number of other human cancers. One gene...
7205136 Catalytic antibodies  
A method for increasing the rate of chemical reactions involving the conversion of at least one reactant to at least one product involves contacting the reactant with an appropriate monoclonal...
7204980 Methods for inhibiting viral replication in vivo  
The present invention is directed to methods of modulating viral replication in vivo comprising administering to an individual a therapeutically or prophylactically effective amount of a...
7202346 Antibodies to non-shed Muc1 and Muc16, and uses thereof  
The present invention relates to antibodies, antibody fragments, conjugates of antibodies and antibody fragments with cytotoxic agents, and hybridomas producing the antibodies and antibody...
7195925 Polymer having an upper critical solution temperature  
The invention relates to a stimulus-responding polymer obtained by polymerizing at least a monomer represented by a general formula (1) and a monomer represented by a general formula (2), and a...
7195923 Ratiometric determination of glycated protein  
The present invention provides methods for determining a ratio of an amount of a glycated form of a protein to a total amount of the protein in a sample containing the glycated protein, the...
7195889 Process for stabilizing enzymes with phosphine or phosphite compounds  
The invention relates to processes for stabilizing the activity of an enzyme, comprising mixing a phosphine or phosphite with an oxidoreductase enzyme.
7186797 Polypeptide conjugates with extended circulating half-lives  
The present invention relates to compounds and methods for synthesizing compounds wherein the compounds exhibit extended circulating half-life in the blood. The increase in circulating half-life is...
RE39497 Storage of materials  
A material or mixture of materials which is not itself storage stable is rendered storage stable by incorporation into a water-soluble or swellable glassy or rubbery composition which can then be...
7172907 Cyanine dye labelling reagents with meso-substitution  
Disclosed are cyanine dyes having meso-substituents in the polymethine chain linking the heterocyclic ring systems. The dyes are of formula (1): in which groups R 3 and R 4 are attached to...
7172905 Polypeptide immobilization  
A substrate comprises a surface, and a plurality of moieties, on at least a portion of the surface. The moieties are moieties of formula:
7172760 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots  
Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots are provided wherein fibrinolytic or anticoagulant drugs are biocompatibly coupled to...
7169590 Method of stabilizing reduced coenzyme Q10 and method of acidic crystallization  
The present invention relates to a method of efficiently producing reduced coenzyme Q 10 having excellent qualities which is useful as an ingredient in foods, functional nutritive foods, specific...